“Starting about then was when you saw the drug companies assert more and more control, until finally over the next couple of decades, they began to treat the researchers as hired hands. They would design the research themselves. You know, you can do a lot of mischief in how you design a trial. Or ‘We’ll test this drug, and we’ll tell you whether it can be published or not.’ And so if it’s a positive study, it’s published. If it’s a negative study, it’ll never see the light of day.”
